About these ads

Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘dermatology retractions’ Category

Alleged Medicare cheat loses paper for data mix-up

leave a comment »

A Boston doctor indicted on charges of Medicare fraud in 2007 has had a paper relating to the case retracted this month.

Abdul Razzaque Ahmed was considered something of a miracle worker by his patients, treating two rare and disfiguring skin conditions called pemphigoid and pemphigus vulgaris. He used more powerful medicines than the typical course of treatment, including a drug normally used to treat cancer.

The initial indictment stated that Ahmed mixed blood samples to falsely show a “dual diagnosis” of both diseases, and prove to Medicare that they required the more rigorous (and expensive) treatment. It also alleged that he profited massively from the government pay-outs. He was convicted of obstruction in 2007; the other charges were dropped when he agreed to forfeit assets worth $2.9 million.

Now, a 2001 paper by Ahmed, which claimed fifteen patients had a dual diagnosis, has been retracted because the samples were all mixed. Here is the retraction notice from Clinical Immunology: Read the rest of this entry »

About these ads

Too much skin in the game, as duplications force retraction of psoriasis paper

with 3 comments

actadermA group of dermatology researchers from Egypt who passed around a psoriasis paper like a bottle of sunscreen at the beach have been burned (sorry) by a journal that caught them in the act.

Acta Dermatovenerologica Alpina, Pannonica et Adriatica is retracting the 2009 article “Association of cytokine gene polymorphisms with psoriasis in cases from the Nile Delta of Egypt” after discovering that they were far from the first publication to print the paper.

Here’s the retraction notice (it’s a pdf): Read the rest of this entry »

Camomile allergy case report retracted after patients withdraw consent post-publication

with 4 comments

aaciIn what may be a first, a researcher in Turkey has withdrawn a paper because the patients whose cases she described wthdrew their consent after it was published.

Here’s the notice, from Allergy, Asthma, & Clinical Immunology, of a paper titled “Severe contact dermatitis due to camomile: a common complementary remedy with potential sensitization risks:” Read the rest of this entry »

Aussie university halts trials of skin cancer drug whose developer has four retractions

with 20 comments

khachigian

Khachigian

An Australian university has put a hold on trials of an experimental drug for skin cancer whose main developer has been dogged by charges of research misconduct for several years.

The Australian Broadcasting Corporation is reporting that the University of New South Wales has suspended trials of the drug, DZ13, while it investigates the work of Levon Khachigian, who is leading the studies.

According to the news organization, Khachigian and his group were cleared by the school in two prior inquiries. However, additional accusations of misconduct — specifically involving image manipulation and misuse — prompted a third investigation.

We’ve found four retractions of Khachigian’s studies, from the Journal of Biological Chemistry and Biochemical and Biophysical Research Communications, between 2009 and 2010 (before the launch of Retraction Watch).

They are: Read the rest of this entry »

Case Western dermatology department hit with second ORI sanction within 6 months

with 9 comments

karnik

Karnik

The Office of Research Integrity (ORI) has sanctioned an assistant professor of dermatology at Case Western Reserve University in Cleveland for plagiarizing from a grant application she was reviewing — which feels like a scientific version of insider trading — and a number of published papers.

According to the ORI’s findings, Pratima Karnik Read the rest of this entry »

Written by Ivan Oransky

August 9, 2013 at 2:30 pm

Figure misuse leads to retraction of wound healing paper

with one comment

biochemengjrnA group of researchers from India and China has lost a 2012 article in the Biochemical Engineering Journal for lifting a figure from a previously published article from another team of investigators. Evidently, caught red-handed, they haven’t copped to the caper.

The article was titled “Purification and characterization of organic solvent and detergent stable protease isolated from marine Saccharopolyspora sp. A9: Application of protease for wound healing.” According to the retraction notice: Read the rest of this entry »

Retraction appears for former Case Western dermatology researcher found by ORI to have falsified data

with 2 comments

mol cell coverBryan William Doreian, who was found by the Office of Research Integrity (ORI) to have falsified data in his Case Western dissertation, has retracted a 2009 paper in Molecular Biology of the Cell also cited by the ORI.

Here’s the notice: Read the rest of this entry »

ORI says Case Western skin scientist falsified data

with 20 comments

molbiolcelldoreianThe U.S. Office of Research Integrity has sanctioned Bryan William Doreian, a former postdoc in dermatology at Case Western Reserve University in Cleveland, for falsifying data in his dissertation and a 2009 paper in Molecular Biology of the Cell (for which it provided a cover image, at right).

ORI says Doreian’s bad NIH-funded data also appeared in a manuscript submitted to, but never published in, Nature Medicine.

Here are the papers cited in the finding: Read the rest of this entry »

Written by amarcus41

February 1, 2013 at 12:21 pm

Double bind: Duplication of bandaging paper leads to retraction

with one comment

The Journal of Vascular Surgery is retracting — with vigor — a paper it published online in March after discovering that the authors had published essentially the same article for the Journal of the European Academy of Dermatology and Venereology some months earlier.

Both papers are titled “Randomized controlled trial comparing treatment outcome of two compression bandaging systems and standard care without compression in patients with venous leg ulcers.” The work was funded by the Health, Welfare and Food Bureau of Hong Kong and a grant from Lohmann & Rauscher GmbH & Co KG, a German company that makes compression bandages and other surgical supplies.

According to the retraction notice in JVS: Read the rest of this entry »

University clears leading dermatology lab head of misconduct as authors issue two corrections

with 8 comments

Michael Hertl, a leading dermatology researcher at Philipps-University Marburg, has been cleared of any wrongdoing in a case that spawned a retraction last year and two just-published retractions.

Felicitas Riedel, a legal officer for the university, tells Retraction Watch that the

…Committee for Scientific Misconduct of the Philipps-University Marburg closed the matter and submitted its results to the President of the University who in the meantime after examination consented with it.

The findings? Read the rest of this entry »

Follow

Get every new post delivered to your Inbox.

Join 33,693 other followers